Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece
Clinical trial NCT06247319 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06247319
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-29
- Primary completion
- 2027-10-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.